TrialNeuro-oncology2018

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143.

Antonio Omuro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.